Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Charles River Laboratories International Inc (NYSE: CRL) was $149.79 for the day, down -3.04% from the previous closing price of $154.48. In other words, the price has decreased by -$3.04 from its previous closing price. On the day, 1.05 million shares were traded. CRL stock price reached its highest trading level at $155.685 during the session, while it also had its lowest trading level at $146.26.
Ratios:
Our analysis of CRL’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 31.95 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.06. For the most recent quarter (mrq), Quick Ratio is recorded 1.16 and its Current Ratio is at 1.43. In the meantime, Its Debt-to-Equity ratio is 0.94 whereas as Long-Term Debt/Eq ratio is at 0.93.
On May 23, 2025, Redburn Atlantic Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $182.
TD Cowen Upgraded its Hold to Buy on May 14, 2025, while the target price for the stock was maintained at $179.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 21 ’25 when WALLMAN RICHARD F bought 8,500 shares for $150.00 per share.
WALLMAN RICHARD F bought 4,000 shares of CRL for $550,000 on Jun 23 ’25. On May 15 ’25, another insider, MASSARO GEORGE, who serves as the Director of the company, sold 140 shares for $137.57 each. As a result, the insider received 19,260 and left with 5,575 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRL now has a Market Capitalization of 7357040128 and an Enterprise Value of 10259750912. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.83 while its Price-to-Book (P/B) ratio in mrq is 2.30. Its current Enterprise Value per Revenue stands at 2.551 whereas that against EBITDA is 11.544.
Stock Price History:
The Beta on a monthly basis for CRL is 1.47, which has changed by -0.321325 over the last 52 weeks, in comparison to a change of 0.13161862 over the same period for the S&P500. Over the past 52 weeks, CRL has reached a high of $254.15, while it has fallen to a 52-week low of $91.86. The 50-Day Moving Average of the stock is 1.76%, while the 200-Day Moving Average is calculated to be -8.80%.
Shares Statistics:
CRL traded an average of 1.09M shares per day over the past three months and 665220 shares per day over the past ten days. A total of 49.12M shares are outstanding, with a floating share count of 48.56M. Insiders hold about 1.12% of the company’s shares, while institutions hold 109.22% stake in the company. Shares short for CRL as of 1749772800 were 2605883 with a Short Ratio of 2.20, compared to 1747267200 on 2761706. Therefore, it implies a Short% of Shares Outstanding of 2605883 and a Short% of Float of 6.1.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
